OrthoAxis

At OrthoAxis orthopedic providers, medical device companies, and medical sales reps share resources, explore opportunities, and simplify workflow. Visit us!

[OrthoAxis @OrthoAxisLLC]

"In postmenopausal women, hormone therapy use conferred higher bone mineral density compared with nonuse. HT use reduced odds of low BMD by 69% in a multivariable analysis."
@GoHealio
https://t.co/SMqHMQG26e

[OrthoAxis @OrthoAxisLLC]

"While challenges remain, the trajectory is clear: orthopedics is moving toward a more connected, intelligent, and patient-centric future."
@OrthoFeed
https://t.co/U5lwPQFKFp

[OrthoAxis @OrthoAxisLLC]

"We are on the threshold of what could become the first truly predictive test to identify children at risk of developing severe scoliosis, opening the door to earlier interventions..."
@orthospinenews
https://t.co/owRQMLuXRP

[OrthoAxis @OrthoAxisLLC]

"Companies that can deliver systems that improve bone stability, streamline surgical workflows and promote faster recovery are positioned to capitalize on this growing market."
@OMTEC_BONEZONE
https://t.co/ZOAcIpbqPg

[OrthoAxis @OrthoAxisLLC]

Medtech for hip arthroplasty keeps getting fancier! Enjoy this article from @MedTechDaily

How J&J’s DePuy Synthes developed Velys software for faster hip replacements
https://t.co/eLRkJCpO5M

[OrthoAxis @OrthoAxisLLC]

“'There are effective treatments for this condition, and many can be performed in an outpatient setting'...The challenge is ensuring patients reach the right specialist before years of lost mobility become their new normal."
@BeckersSpine
https://t.co/YLzJJctspD

[OrthoAxis @OrthoAxisLLC]

"Rather than focusing exclusively on prestige indicators, such as impact factors, researchers should evaluate editorial standards, credibility, transparency, and methodological rigor."
@Medscape
Choosing a Journal: What Matters More Than Impact Factor?
https://t.co/YRgagIJBnI

[OrthoAxis @OrthoAxisLLC]

"By repurposing an existing medication and delivering it through a high-tech smart gel, researchers have discovered a way to potentially protect joints and provide long-lasting relief without the need for addictive opioids."
@medical_xpress
https://t.co/jgKzpdmrUm

[OrthoAxis @OrthoAxisLLC]

"Joint Commission's goal is to provide governance support for delivering the safest and highest quality care for U.S. health systems across the care continuum..."
@HealthITNews
Joint Commission intros new voluntary AI responsibility certification
https://t.co/52xtwIo9VW

[OrthoAxis @OrthoAxisLLC]

“Our focus is to really change the direction of surgery for as many patients as possible around the world....The technology is available. All these things can be done.”
@MedTechDaily
https://t.co/p33rmj2QL2

[OrthoAxis @OrthoAxisLLC]

This article from ORTHOWORLD shares a conversation with Sariah Khormaee, M.D., Ph.D., the CEO of SIGN Fracture Care International, discussing their mission, methods and future plans.
@ORTHOWORLDInc
https://t.co/5xbpzi4DbS

[OrthoAxis @OrthoAxisLLC]

"As orthopedics sees a decline in the number of physicians in the specialty, surgeons say practices will have to adapt to stay afloat."
@BeckersSpine
https://t.co/p2dykwEVIl

[OrthoAxis @OrthoAxisLLC]

This article from @OrthopaedicPN looks at the IDTechEx report, "Materials for Bone Implants 2026-2036: Trends, Players, and Forecasts" and what it says about key drivers in the hip and knee arthroplasty market.
https://t.co/MLfGjS6VJq

[OrthoAxis @OrthoAxisLLC]

"Ultimately, the next wave of innovation in orthobiologics will not be defined solely by new materials but by how effectively companies can align biological science, patient-specific application, and data-driven validation."
@ODTmagazine
https://t.co/odVmWb0zeL

[OrthoAxis @OrthoAxisLLC]

"This narrative review aims to synthesize current knowledge on wound closure techniques in TKA, explore biomechanical considerations, evaluate postoperative management strategies, and identify gaps in the literature..."
@JOEI_TheJournal
https://t.co/XCbjW0iVWT

[OrthoAxis @OrthoAxisLLC]

"Ultimately, our study highlights the need to rethink how we define success in TKA. Success should not be measured solely by measurable improvement, but by the meaningful benefit it provides to patients."
@jbjs
https://t.co/pAjgjF29pr

[OrthoAxis @OrthoAxisLLC]

"In this randomized trial, no benefit from amoxicillin-clavulanate could be discerned for patients with refractory low back pain and herniated discs at 1 year."
@medpagetoday
https://t.co/KLNidiQhT9

[OrthoAxis @OrthoAxisLLC]

"The cryopreserved and fresh osteochondral allograft groups had no differences in revision surgery or conversion to arthroplasty. IKDC scores also remained similar among the two groups."
@GoHealio
https://t.co/F8OPKuHQBr

[OrthoAxis @OrthoAxisLLC]

"This study doesn’t show that AI failed. It shows where the logic boundaries are currently. And it sharpened the relevant question for judging AI radiology systems."
@Ryortho1
https://t.co/n2rEuK6cQv

[OrthoAxis @OrthoAxisLLC]

"Research identifies three steps to reassure patients effectively: establish understanding, share clinical rationale, and give an explicit stance."
@Medscape
New Data Peg Three Key Steps for Reassuring Worried Patients
https://t.co/9bPKHulExe